349 related articles for article (PubMed ID: 18289797)
1. Application of stem cell markers in search for neoplastic germ cells in dysgenetic gonads, extragonadal tumours, and in semen of infertile men.
Hoei-Hansen CE
Cancer Treat Rev; 2008 Jun; 34(4):348-67. PubMed ID: 18289797
[TBL] [Abstract][Full Text] [Related]
2. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects.
Rajpert-De Meyts E
Hum Reprod Update; 2006; 12(3):303-23. PubMed ID: 16540528
[TBL] [Abstract][Full Text] [Related]
3. Stem cell factor as a novel diagnostic marker for early malignant germ cells.
Stoop H; Honecker F; van de Geijn GJ; Gillis AJ; Cools MC; de Boer M; Bokemeyer C; Wolffenbuttel KP; Drop SL; de Krijger RR; Dennis N; Summersgill B; McIntyre A; Shipley J; Oosterhuis JW; Looijenga LH
J Pathol; 2008 Sep; 216(1):43-54. PubMed ID: 18566970
[TBL] [Abstract][Full Text] [Related]
4. A subfertile patient diagnosed with testicular carcinoma in situ by immunocytological staining for AP-2gamma in semen samples: case report.
Hoei-Hansen CE; Rajpert-De Meyts E; Carlsen E; Almstrup K; Leffers H; Skakkebaek NE
Hum Reprod; 2005 Mar; 20(3):579-82. PubMed ID: 15650041
[TBL] [Abstract][Full Text] [Related]
5. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights.
Looijenga LH
J Pathol; 2009 Jun; 218(2):146-62. PubMed ID: 19253916
[TBL] [Abstract][Full Text] [Related]
6. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia.
Cheng L; Sung MT; Cossu-Rocca P; Jones TD; MacLennan GT; De Jong J; Lopez-Beltran A; Montironi R; Looijenga LH
J Pathol; 2007 Jan; 211(1):1-9. PubMed ID: 17117392
[TBL] [Abstract][Full Text] [Related]
7. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.
Kersemaekers AM; Honecker F; Stoop H; Cools M; Molier M; Wolffenbuttel K; Bokemeyer C; Li Y; Lau YF; Oosterhuis JW; Looijenga LH
Hum Pathol; 2005 May; 36(5):512-21. PubMed ID: 15948118
[TBL] [Abstract][Full Text] [Related]
8. Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis.
Looijenga LH; Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW
Ann N Y Acad Sci; 2007 Dec; 1120():187-214. PubMed ID: 17911410
[TBL] [Abstract][Full Text] [Related]
9. Screening of subfertile men for testicular carcinoma in situ by an automated image analysis-based cytological test of the ejaculate.
Almstrup K; Lippert M; Mogensen HO; Nielsen JE; Hansen JD; Daugaard G; Jørgensen N; Foged NT; Skakkebaek NE; Rajpert-De Meyts E
Int J Androl; 2011 Aug; 34(4 Pt 2):e21-30; discussion e30-1. PubMed ID: 21696398
[TBL] [Abstract][Full Text] [Related]
10. Clinical and biological significance of carcinoma in situ of the testis.
Jørgensen N; Müller J; Giwercman A; Skakkebaek NE
Cancer Surv; 1990; 9(2):287-302. PubMed ID: 1964624
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.
Hoei-Hansen CE; Nielsen JE; Almstrup K; Sonne SB; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Clin Cancer Res; 2004 Dec; 10(24):8521-30. PubMed ID: 15623634
[TBL] [Abstract][Full Text] [Related]
12. Towards a non-invasive method for early detection of testicular neoplasia in semen samples by identification of fetal germ cell-specific markers.
Hoei-Hansen CE; Carlsen E; Jorgensen N; Leffers H; Skakkebaek NE; Rajpert-De Meyts E
Hum Reprod; 2007 Jan; 22(1):167-73. PubMed ID: 16920726
[TBL] [Abstract][Full Text] [Related]
13. Spermatogenesis in the contralateral testis of patients with testicular germ cell cancer: histological evaluation of testicular biopsies and a comparison with healthy males.
Dieckmann KP; Linke J; Pichlmeier U; Kulejewski M; Loy V;
BJU Int; 2007 May; 99(5):1079-85. PubMed ID: 17244285
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive detection of testicular carcinoma in situ in semen using OCT3/4.
van Casteren NJ; Stoop H; Dohle GR; de Wit R; Oosterhuis JW; Looijenga LH
Eur Urol; 2008 Jul; 54(1):153-8. PubMed ID: 17996359
[TBL] [Abstract][Full Text] [Related]
15. Lack of RBM expression as a marker for carcinoma in situ of prepubertal dysgenetic testis.
Schreiber L; Lifschitz-Mercer B; Paz G; Yavetz H; Zadik Z; Kula K; Slowikowska-Hilczer J; Rey R; Elliott DJ; Maymon BB
J Androl; 2003; 24(1):78-84. PubMed ID: 12514087
[TBL] [Abstract][Full Text] [Related]
16. Genomic and gene expression signature of the pre-invasive testicular carcinoma in situ.
Almstrup K; Ottesen AM; Sonne SB; Hoei-Hansen CE; Leffers H; Rajpert-De Meyts E; Skakkebaek NE
Cell Tissue Res; 2005 Oct; 322(1):159-65. PubMed ID: 15846514
[TBL] [Abstract][Full Text] [Related]
17. A novel double staining strategy for improved detection of testicular carcinoma in situ cells in human semen samples.
Nielsen JE; Kristensen DM; Almstrup K; Jørgensen A; Olesen IA; Jacobsen GK; Horn T; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Andrologia; 2012 Apr; 44(2):78-85. PubMed ID: 21486421
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
[TBL] [Abstract][Full Text] [Related]
19. Origin of pluripotent germ cell tumours: the role of microenvironment during embryonic development.
Kristensen DM; Sonne SB; Ottesen AM; Perrett RM; Nielsen JE; Almstrup K; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Mol Cell Endocrinol; 2008 Jun; 288(1-2):111-8. PubMed ID: 18420341
[TBL] [Abstract][Full Text] [Related]
20. Less advanced testicular dysgenesis is associated by a higher prevalence of germ cell neoplasia.
Guminska A; Oszukowska E; Kuzanski W; Sosnowski M; Wolski JK; Walczak-Jedrzejowska R; Marchlewska K; Niedzielski J; Kula K; Slowikowska-Hilczer J
Int J Androl; 2010 Feb; 33(1):e153-62. PubMed ID: 19719533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
